TrialHuman vaccines & immunotherapeutics2016

Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.

Kai Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.